Heme oxygenase-1 in cardiovascular diseases: molecular mechanisms and clinical perspectives

Chao-Yung Wang1, Lee-Young Chau

  • 1Second Section of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Chang Gung Medical Journal
|February 27, 2010
PubMed

Insights

Heme oxygenase-1 (HO-1) is a stress-induced enzyme protecting against oxidative injury through its antioxidant and anti-inflammatory products. Its role is crucial in various diseases, particularly cardiovascular conditions.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Physiology

Background:

  • Heme oxygenase (HO) is key in heme degradation, producing iron, carbon monoxide (CO), and biliverdin.
  • HO-1 is a stress-inducible isoform, unlike the constitutive HO-2.
  • HO-1 induction is triggered by diverse stimuli including cytokines, endotoxin, heavy metals, nitric oxide, and heme.

Purpose of the Study:

  • To review the regulation and function of HO-1.
  • To highlight HO-1's defensive role against oxidative stress.
  • To focus on HO-1's involvement in cardiovascular diseases.

Main Methods:

  • Literature review of molecular mechanisms and clinical perspectives.
  • Analysis of HO-1's role in cellular stress responses.
  • Examination of HO-1's function in various physiological and pathophysiological states.

Main Results:

  • HO-1 induction acts as a defense mechanism against oxidative injury.
  • The products of HO-1 (CO, biliverdin, bilirubin) possess antioxidant and anti-inflammatory properties.
  • HO-1 is implicated in diseases such as coronary artery disease, cardiac hypertrophy, diabetes, and atherosclerosis.

Conclusions:

  • HO-1 plays a significant role in cellular defense against oxidative stress.
  • HO-1's functions extend to various clinical conditions, especially cardiovascular diseases.
  • Understanding HO-1 regulation and function offers therapeutic insights for oxidative stress-related diseases.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...